Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy C Nichols

Blood

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Blood|November 23, 2013
Bad cholesterol breaking really badTimothy C Nichols
Blood|June 14, 2003
A gene-deleted adenoviral vector results in phenotypic correction of canine hemophilia B without liver toxicity or thrombocytopeniaAnja Ehrhardt, Hui Xu, Aaron M Dillow, et al.
Blood|August 28, 2004
Re-establishment of VWF-dependent Weibel-Palade bodies in VWD endothelial cellsSandra L Haberichter, Elizabeth P Merricks, Scot A Fahs, et al.
Blood|January 8, 2005
Sustained correction of disease in naive and AAV2-pretreated hemophilia B dogs: AAV2/8-mediated, liver-directed gene therapyLili Wang, Roberto Calcedo, Timothy C Nichols, et al.
Blood|August 2, 2003
PECAM-1 negatively regulates GPIb/V/IX signaling in murine plateletsVipul Rathore, Michelle A Stapleton, Cheryl A Hillery, et al.
Blood|October 14, 2004
Regional intravascular delivery of AAV-2-F.IX to skeletal muscle achieves long-term correction of hemophilia B in a large animal modelValder R Arruda, Hansell H Stedman, Timothy C Nichols, et al.
Blood|August 25, 2012
The efficacy and the risk of immunogenicity of FIX Padua (R338L) in hemophilia B dogs treated by AAV muscle gene therapyJonathan D Finn, Timothy C Nichols, Nikolaos Svoronos, et al.
Blood|January 18, 2003
Neonatal or hepatocyte growth factor-potentiated adult gene therapy with a retroviral vector results in therapeutic levels of canine factor IX for hemophilia BLingfei Xu, Cuihua Gao, Mark S Sands, et al.
Blood|September 13, 2003
Safety and efficacy of factor IX gene transfer to skeletal muscle in murine and canine hemophilia B models by adeno-associated viral vector serotype 1Valder R Arruda, Joerg Schuettrumpf, Roland W Herzog, et al.
Blood|September 23, 2009
Recombinant canine B-domain-deleted FVIII exhibits high specific activity and is safe in the canine hemophilia A modelDenise E Sabatino, Christian Furlan Freguia, Raffaella Toso, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Blood|November 23, 2013
Bad cholesterol breaking really badTimothy C Nichols
Blood|June 14, 2003
A gene-deleted adenoviral vector results in phenotypic correction of canine hemophilia B without liver toxicity or thrombocytopeniaAnja Ehrhardt, Hui Xu, Aaron M Dillow, et al.
Blood|August 28, 2004
Re-establishment of VWF-dependent Weibel-Palade bodies in VWD endothelial cellsSandra L Haberichter, Elizabeth P Merricks, Scot A Fahs, et al.
Blood|January 8, 2005
Sustained correction of disease in naive and AAV2-pretreated hemophilia B dogs: AAV2/8-mediated, liver-directed gene therapyLili Wang, Roberto Calcedo, Timothy C Nichols, et al.
Blood|August 2, 2003
PECAM-1 negatively regulates GPIb/V/IX signaling in murine plateletsVipul Rathore, Michelle A Stapleton, Cheryl A Hillery, et al.
Blood|October 14, 2004
Regional intravascular delivery of AAV-2-F.IX to skeletal muscle achieves long-term correction of hemophilia B in a large animal modelValder R Arruda, Hansell H Stedman, Timothy C Nichols, et al.
Blood|August 25, 2012
The efficacy and the risk of immunogenicity of FIX Padua (R338L) in hemophilia B dogs treated by AAV muscle gene therapyJonathan D Finn, Timothy C Nichols, Nikolaos Svoronos, et al.
Blood|January 18, 2003
Neonatal or hepatocyte growth factor-potentiated adult gene therapy with a retroviral vector results in therapeutic levels of canine factor IX for hemophilia BLingfei Xu, Cuihua Gao, Mark S Sands, et al.
Blood|September 13, 2003
Safety and efficacy of factor IX gene transfer to skeletal muscle in murine and canine hemophilia B models by adeno-associated viral vector serotype 1Valder R Arruda, Joerg Schuettrumpf, Roland W Herzog, et al.
Blood|September 23, 2009
Recombinant canine B-domain-deleted FVIII exhibits high specific activity and is safe in the canine hemophilia A modelDenise E Sabatino, Christian Furlan Freguia, Raffaella Toso, et al.
Pageof 2